|

Placebo + docetaxel Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: Placebo

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Charles Drew University of Medicine and Science1
  • Akeso1

Indications

  • Cancer2
  • Metastatic Castration-resistant Prostate Cancer, mCRPC1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1

Other1 trial

Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
Phase 3

Los Angeles, California1 trial

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

Charles R. Drew University of Medicine and Science

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.